서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 12 of 12

Issue DateTitle / Author(s) / CitationFileAltmetrics
2000
Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors
DOI
2001-05
Apoptosis and megakaryocytic differentiation during ex vivo expansion of human cord blood CD34(+) cells using thrombopoietin

Ryu, KH; Chun, S; Carbonierre, S; Im, Seock Ah; Kim, HL; Shin, MH; Shin, HY; Ahn, HS; Woo, SY; Seoh, JY; Fraser, JK

British Journal of Haematology, Vol.113 No.2, pp.470-478

DOI
2002-01
Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34(+) cells using thrombopoietin
DOI
2003-03
Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion
DOI
2003-12
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients - Comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage
DOI
2004-11
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2005-12
Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis

Park, H; Jung, YK; Park, OJ; Lee, YJ; Choi, JY; Choi, YN

Journal of Immunology, Vol.175 No.11, pp.7193-7201

DOI
2005-12
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
DOI
2007-09
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
view file
2016-04
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
DOI
2022-12
Mycobacterium intracellulare induces a Th17 immune response via M1-like macrophage polarization in canine peripheral blood mononuclear cells

Kim, Suji; Hyun, You-Seok; Park, Hong-Tae; Shin, Min-Kyung; Yoo, Han Sang

Scientific Reports, Vol.12 No.1, p. 11818

DOI
2023-07
Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies
DOI
1